In an exploratory article on of the explosive growth of personalized medicine and the important role technology plays in this paradigm shift, Coriell Institute's president and CEO, Dr. Michael Christman discusses the work being done by the Coriell Personalized Medicine Collaborative research study.
"I believe that understanding more about how patients process this information—if they make any lifestyle behavior changes, for instance—will influence the way physicians determine health management strategies," Dr. Christman told Caitlin Smith, a reporter with Genetic Engineering & Biotechnology News, a top industry publication.
"Our goal is to empower the next generation of medical professionals with access to the top sequence providers and genome interpretation models in order to arrive at the most optimized health solutions," Christman notes in the piece.
Smith also speaks with several other noteworthy organizations operating in this hi-tech space, including the founder and president of GeneKey, an outfit examining the role genetics plays in cancer treatment.
Click here to read the full article.
